200
Participants
Start Date
August 4, 2022
Primary Completion Date
August 7, 2026
Study Completion Date
August 7, 2026
M9140
M9140 will be administered at an escalated dose until Maximum tolerated dose (MTD) and/or a safe recommended Dose for Expansion (RDE) is determined in Part 1 of the study.
M9140
M9140 will be further investigated in part 2 of the study and includes dose optimization, an alternative administration regimen and combination regimen.
Bevacizumab
Bevacizumab will be administered intravenously as per standard of care.
Capecitabine
Capecitabine will be administered orally as per standard of care.
5-fluorouracil (5-FU)
5-FU will be administered intravenously as per standard of care.
Folinic acid
Folinic acid will be administered intravenously as per standard of care.
RECRUITING
Mary Crowley Cancer Research, Dallas
RECRUITING
MD Anderson Cancer Center - Oncology, Houston
RECRUITING
NEXT Oncology, San Antonio
COMPLETED
California Cancer Associates for Research & Excellence, Inc., Encinitas
COMPLETED
California Cancer Associates for Research & Excellence, Inc., Fresno
RECRUITING
Rhode Island Hospital, Providence
RECRUITING
The Ottawa Hospital Cancer Centre, Ottawa
RECRUITING
University Health Network - Princess Margaret Cancer Centre, Toronto
RECRUITING
National Cancer Center Hospital - Dept of Gastroenterology, Chūōku
RECRUITING
National Cancer Center Hospital East, Kashiwa-shi
RECRUITING
Saitama Cancer Center, Kitaadachi-gun
RECRUITING
Cancer Institute Hospital of JFCR, Kōtoku
RECRUITING
Aichi Cancer Center Hospital, Nagoya
RECRUITING
Kindai University Hospital, Osakasayama-shi
RECRUITING
Shizuoka Cancer Center, Sunto-gun
RECRUITING
Kanagawa Cancer Center, Yokohama
RECRUITING
Kyungpook National University Chilgok Hospital, Daegu
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
Seoul National University Bundang Hospital, Seongnam
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Hospital Clinic de Barcelona, Barcelona
RECRUITING
Hospital del Mar, Barcelona
RECRUITING
Hospital HM Nou Delfos, Barcelona
RECRUITING
Hospital Universitari Vall d'Hebron - VHIR, Barcelona
RECRUITING
Hospital Universitario Reina Sofia, Córdoba
RECRUITING
ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat
RECRUITING
Centro Integral Oncologico Clara Campal, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Universitario Fundacion Jimenez Diaz, Madrid
RECRUITING
Hospital Universitario Quironsalud Madrid - NEXT Oncology, Madrid
RECRUITING
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
Merck KGaA, Darmstadt, Germany
INDUSTRY
EMD Serono Research & Development Institute, Inc.
INDUSTRY